Back to Screener

Industrials

Atlas Arteria Limited(MAQAF)

Live Price

Offline

$3.38

+0.00% today

1Y Change

+2.29%

Window

Jun 26, 2025 โ†’ Jun 24, 2026

Market Cap
$6.96B
Revenue Growth
+10.3%
EPS Growth
-21.7%
Dividend Yield
8.3%

Coverage: 249 bars ยท Jun 26, 2025 โ†’ Jun 24, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Atlas Arteria Limited (MAQAF) is a Industrials stock with a market cap of $6.96B and listed on OTC. The stock last traded around $3.38 and up 2.3% across the available one-year price window (Jun 26, 2025 โ†’ Jun 24, 2026). Baseline metrics include revenue growth of +10.3%, EPS growth of -21.7%, a dividend yield of 8.3%. What stands out right now is revenue +10.3%, EPS -21.7%, free cash flow +565.8% with operating margin 9.4% and ROIC 0.1%. The dividend matters to the case here, with a current yield around 8.3%. Valuation already assumes a fairly strong business story at P/E 33.8 and price/sales 57.4. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines MAQAF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Industrials peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Above sector median

+10.3% vs +6.8% peer median

Operating Margin

Below sector median

+9.4% vs +16.9% peer median

P/E

Below sector median

33.8 vs 36.7 peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report came in below the EPS bar

2026 was reported on Feb 25, 2026 with an EPS surprise of -1.4% and a revenue surprise of -41.2%.

The operating picture looks softer than before

Revenue is at +10.3% and EPS is at -21.7%, with operating margin around 9.4%.

The next real check-in already has a date

The next earnings event is scheduled for Sep 2, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.

Earnings Reaction Memory

How the stock has tended to move after recent reports.

Across the last 3 reported quarters, the stock averaged -0.9% over the next 5 trading days and finished higher after 0 of those reports.

View quarter-by-quarter reaction table
QuarterEPS ฮ”1D5D20D
2026
Feb 25, 2026
-1.4%+0.0%-2.7%-12.5%
2025
Aug 27, 2025
-59.6%+0.0%+0.0%+1.4%
2025
Feb 27, 2025
-43.5%+0.0%+0.0%+0.0%

Benchmark Edge

MAQAF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

MAQAF

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

MAQAF Max Drawdown

-24.23%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for MAQAF and SPY.

Calendar-year return history is still loading or unavailable.
Atlas Arteria Limited logo

Company Overview

Atlas Arteria Limited

Other OTC

Atlas Arteria Limited owns, develops, and operates toll roads. It holds a 13.4% interest in 22-kilometer toll road investors partnership II (TRIP II), the concessionaire for Dulles Greenway toll road located in Virginia, the United States. The company was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018. Atlas Arteria Limited was incorporated in 2009 and is based in Melbourne, Australia.

Leadership
Hugh Wehby DipInvRel
IPO Date
Oct 15, 2010
Employees
50
Street Address
180 Flinders Street
Mailing
Melbourne, VIC, 3000
Region
Melbourne, VIC, AU
Reporting Currency
USD
Investor Line
61 4 3849 3692
Last Updated
May 2, 2026
ISIN: AU0000013559
Reports in USD

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
33.8
EV/EBITDA
208.1
Price/Sales
57.4
Price/Book
1.2

Growth

Revenue
+10.3%
EPS
-21.7%
Free Cash Flow
+565.8%

Profitability

Gross Margin
23.8%
Operating Margin
9.4%
Net Margin
169.8%
ROE
3.5%
ROIC
0.1%

Balance Sheet

Debt/Equity
0.30
Current Ratio
2.17

Earnings Reports

๐Ÿ“… Next earningsSep 2, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
Sep 2, 26
TBD
โ€”
Est 0.03
โ€”
โ€”
Est 118965.5B
โ€”
โ€”
Feb 25, 26
โœ—
0.20
Est 0.20
-1.4%
55048.1B
Est 93681.9B
-41.2%
โ€”
Aug 27, 25
โœ—
0.05
Est 0.12
-59.6%
50776.4B
Est 115405.3B
-56.0%
โ€”
Feb 27, 25
โœ—
0.09
Est 0.17
-43.5%
46668.1B
Est โ€”
โ€”
โ€”
Aug 29, 24
โœ—
0.05
Est 0.12
-57.3%
46406.5B
Est 47328.6B
-1.9%
โ€”
May 16, 24
โœ—
0.06
Est 0.18
-69.6%
47997.0B
Est 51739.3B
-7.2%
โ€”
Jun 30, 23
0.06
Est โ€”
โ€”
42170.3B
Est 45288.0B
-6.9%
โ€”
Dec 31, 22
โœ—
0.07
Est 0.11
-36.9%
43750.9B
Est 42879.9B
+2.0%
โ€”
Jun 30, 22
โœ—
0.08
Est 0.08
-6.4%
37280.6B
Est 45541.3B
-18.1%
โ€”
Dec 31, 21
โœ—
0.07
Est 0.07
-12.4%
41339.0B
Est 47156.2B
-12.3%
โ€”
Jun 30, 21
โœ“
0.05
Est 0.05
+5.8%
32645.7B
Est 40576.6B
-19.6%
โ€”
Dec 31, 20
โœ—
0.05
Est 0.06
-12.9%
36251.9B
Est 42842.2B
-15.4%
โ€”
Jun 30, 20
โœ—
-0.09
Est 0.03
-377.7%
39692.7B
Est 34535.9B
+14.9%
โ€”
Dec 31, 19
โœ—
0.06
Est 0.12
-50.8%
59987.4B
Est 57982.7B
+3.5%
โ€”
Jun 30, 19
-0.08
Est โ€”
โ€”
57650.8B
Est โ€”
โ€”
โ€”
Dec 31, 18
0.05
Est โ€”
โ€”
56307.9B
Est โ€”
โ€”

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.